Skip to main content
. 2022 Mar 29;322(6):R467–R485. doi: 10.1152/ajpregu.00017.2022

Table 2.

Tissue masses after 3 wk of DOCA-salt or sham treatment, corrected for body mass or tibia length by GLM

End Point 5L0D
(n = 8, 8)
2920x
(n = 8, 8)
7913
(n = 8, 8)
P Value
Corrected model Body mass Tibia length Diet DOCA Diet × DOCA
Interscapular fat, mg
 Sham 83 ± 45 106 ± 36 112 ± 37 0.32 0.07 0.48 0.30 0.53 0.75
 DOCA-salt 28 ± 38 111 ± 36 105 ± 35
Perigonadal fat, mg
 Sham 224 ± 35 333 ± 32 355 ± 32 <0.01 <0.01 0.56 <0.01 <0.01 0.93
 DOCA-salt 400 ± 34 485 ± 32 509 ± 31
Perirenal fat, mg
 Sham 49 ± 76 83 ± 69 178 ± 69 0.79 0.53 0.39 0.90 0.40 0.34
 DOCA-salt 208 ± 73 136 ± 69 106 ± 66
Inguinal fat, mg
 Sham 120 ± 24 175 ± 21 173 ± 22 0.02 0.14 0.45 0.05 <0.01 0.71
 DOCA-salt 180 ± 23 205 ± 22 232 ± 22
Liver, g
 Sham 1.01 ± 0.09 1.06 ± 0.08 1.14 ± 0.08 <0.01 0.04 0.03 <0.01 <0.01 0.06
 DOCA-salt 1.32 ± 0.09 1.80 ± 0.08 1.66 ± 0.08
Heart ventricles, mg
 Sham 107 ± 3 115 ± 3 94 ± 3 <0.01 0.13 0.03 <0.01 0.68 0.02
 DOCA-salt 104 ± 3 107 ± 3 102 ± 3
Adrenal glands, mg
 Sham 3.9 ± 0.5 3.2 ± 0.4 2.9 ± 0.4 0.44 0.64 0.79 0.21 0.09 0.85
 DOCA-salt 3.0 ± 0.4 2.6 ± 0.4 2.6 ± 0.4
Kidneys, mg
 Sham 338 ± 14 329 ± 13 305 ± 13 <0.01 0.13 0.50 0.19 <0.01 0.65
 DOCA-salt 424 ± 14 434 ± 13 416 ± 12
Spleen, mg
 Sham 59 ± 4 68 ± 3 58 ± 3 <0.01 0.52 0.98 0.02 <0.01 0.32
 DOCA-salt 46 ± 3 59 ± 3 55 ± 3

Data analyzed by GLM and presented as (EMM) ± SE after consideration of covariates at body mass = 25.44 g, tibia length = 1.86 cm. DOCA, deoxycorticosterone acetate. EMM, estimated marginal means; GLM, generalized linear model.